Analyst Research

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Greatbatch Inc Sees FY 2013 Revenue Guidance At Lower End Of Prior Range; Sees FY 2013 EPS Guidance At Mid-Point Or Better Prior Range


Thursday, 24 Oct 2013 04:05pm EDT 

Greatbatch Inc announced that based upon its results for the first three quarters, as well as the Company's expectations for the remainder of 2013, the Company continue to believe that revenue for fiscal 2013 to be at the lower end of its original sales guidance of $660 million to $680 million provided at the beginning of the year. If achieved, this would result in organic revenue growth of 5% - 8% after adjusting for the disposition of $15 million of non-core orthopaedic product lines at the end of 2012. Because of the Company's strong productivity performance and favorable mix of product sales the Company believe that its adjusted diluted EPS will be at the mid-point or better of its previous $2.05 to $2.15 guidance. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $664 million and EPS of $2.09 for fiscal 2013